MESO: Mesoblast Limited Company Buyout Price

Corporate company logo of Mesoblast Pharma (MESO)

This chart of Mesoblast Limited (MESO) valuation history on the GURU.Markets platform, where the Enterprise Value stands at 1739.27, illustrates a period of a critical strategic pivot aimed at securing licenses for key developments. Business revenues will be based on the market launch of allogeneic therapies for treating cardiac pathologies. As a regenerative medicine innovator, Mesoblast Limited (MESO) is developing tissue restoration methods using stem cells.

MESO (Mesoblast Corp) Total Company Value history from 11/23/2025 to 10/28/2026

Financial and market metric breakdowns for Mesoblast Limited (MESO)

- price and consensus price forecast:
Market Price Mesoblast Ltd|MESO - Price Target Chart
- market capitalization data:
Market Capitalization Mesoblast|MESO - Total Company Value
- book capitalization data:
Net Asset Value per Share Mesoblast|MESO - Company Book Value|Market Capitalization to Book Value mesoblast.com|MESO - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital Mesoblast Limited|MESO - Long-Term Debt to Capital|Current Liabilities to Capital mesoblast.com|MESO - Company Debts|Debt to Book Value Mesoblast|MESO - Company Long-Term Debts|Company Current Liabilities Mesoblast
Fundamental company valuation:MESO (Mesoblast Ltd)
Original product of Mesoblast Corp

Enterprise Value (EV) represents the total buyout price of a business, combining market capitalization and net debt to determine the actual cost of acquiring an asset. By analyzing the total asset value inclusive of net debt, an investor can see how Mesoblast Limited (MESO) dependence on secondary offerings and the risk of FDA rejections impact the company's fundamental valuation amid high operating expenses.

Competitor analysis for Mesoblast Limited

Lineage Cell Therapeutics Inc - Total Enterprise Value|Total Company Value SRZN (Surrozen Corp)|CCEL: Company Buyout Price|Total Company Value FBLG|LGVN (longeveron.com) - Total Enterprise Value|BRTX: Total Company Value|Company Buyout Price Creative Medical Technology Holdings Inc. (CELZ)